Changes in blood-volume produced by treatment in the nephrotic syndrome.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001810:Blood Volume; D001811:Blood Volume Determination; D001835:Body Weight; D002648:Child; D002740:Chlorothiazide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005260:Female; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011187:Posture; D011241:Prednisone / Q000627:therapeutic use; D012709:Serum Albumin; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D004232:Diuretics; D012709:Serum Albumin; D013148:Spironolactone; D002740:Chlorothiazide; D004976:Ethacrynic Acid; D011241:Prednisone; D014223:Triamterene